• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Eur Arch Otorhinolaryngol . Distinct smell and taste disorder phenotype of post-acute COVID-19 sequelae

tetano

Editor, Senior Moderator
Eur Arch Otorhinolaryngol


. 2023 Sep 5.
doi: 10.1007/s00405-023-08163-x. Online ahead of print. Distinct smell and taste disorder phenotype of post-acute COVID-19 sequelae

Verena Rass[SUP] 1 [/SUP], Piotr Tymoszuk[SUP] 2 [/SUP], Sabina Sahanic[SUP] 3 [/SUP], Beatrice Heim[SUP] 1 [/SUP], Dietmar Ausserhofer[SUP] 4 [/SUP], Anna Lindner[SUP] 1 [/SUP], Mario Kofler[SUP] 1 [/SUP], Philipp Mahlknecht[SUP] 1 [/SUP], Anna Boehm[SUP] 3 [/SUP], Katharina Hüfner[SUP] 5 [/SUP], Alex Pizzini[SUP] 3 [/SUP], Thomas Sonnweber[SUP] 3 [/SUP], Katharina Kurz[SUP] 3 [/SUP], Bernhard Pfeifer[SUP] 6 7 [/SUP], Stefan Kiechl[SUP] 1 [/SUP], Marina Peball[SUP] 1 [/SUP], Philipp Kindl[SUP] 1 [/SUP], Lauma Putnina[SUP] 1 [/SUP], Elena Fava[SUP] 1 [/SUP], Atbin Djamshidian[SUP] 1 [/SUP], Andreas Huber[SUP] 6 [/SUP], Christian J Wiedermann[SUP] 4 [/SUP], Barbara Sperner-Unterweger[SUP] 5 [/SUP], Ewald Wöll[SUP] 8 [/SUP], Ronny Beer[SUP] 1 [/SUP], Alois Josef Schiefecker[SUP] 1 [/SUP], Rosa Bellmann-Weiler[SUP] 3 [/SUP], Herbert Bachler[SUP] 9 [/SUP], Ivan Tancevski[SUP] 3 [/SUP], Bettina Pfausler[SUP] 1 [/SUP], Giuliano Piccoliori[SUP] 4 [/SUP], Klaus Seppi[SUP] 1 [/SUP], Günter Weiss[SUP] 3 [/SUP], Judith Löffler-Ragg[SUP] 10 [/SUP], Raimund Helbok[SUP] 11 12 [/SUP]



Affiliations
Abstract

Purpose: Olfactory dysfunction (OD) commonly accompanies coronavirus disease 2019 (COVID-19). We investigated the kinetics of OD resolution following SARS-CoV-2 infection (wild-type and alpha variant) and its impact on quality of life, physical and mental health.
Methods: OD prevalence was assessed in an ambulatory COVID-19 survey (n = 906, ≥ 90 days follow-up) and an observational cohort of ambulatory and hospitalized individuals (n = 108, 360 days follow-up). Co-occurrence of OD with other symptoms and effects on quality of life, physical and mental health were analyzed by multi-dimensional scaling, association rule mining and semi-supervised clustering.
Results: Both in the ambulatory COVID-19 survey study (72%) and the observational ambulatory and hospitalized cohort (41%) self-reported OD was frequent during acute COVID-19. Recovery from self-reported OD was slow (survey: median 28 days, observational cohort: 90 days). By clustering of the survey data, we identified a predominantly young, female, comorbidity-free group of convalescents with persistent OD and taste disorders (median recovery: 90 days) but low frequency of post-acute fatigue, respiratory or neurocognitive symptoms. This smell and taste disorder cluster was characterized by a high rating of physical performance, mental health, and quality of life as compared with convalescents affected by prolonged fatigue or neurocognitive complaints.
Conclusion: Our results underline the heterogeneity of post-acute COVID-19 sequelae calling for tailored management strategies. The persistent smell and taste disorder phenotype is characterized by good clinical, physical, and mental recovery and may pose a minor challenge for public health.
Study registration: ClinicalTrials.gov: NCT04661462 (survey study), NCT04416100 (observational cohort).

Keywords: Long COVID; Mental health; Olfactory dysfunction; Post-COVID-19 condition; Quality of life; Smell and taste disorder.

 
Back
Top Bottom